Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | Both sides next revision |
accelerating_covid-19_therapeutic_interventions_and_vaccines [2022/08/17 17:41]
liam | accelerating_covid-19_therapeutic_interventions_and_vaccines [2023/07/02 20:47] (current)
liam |
|---|
| | [[Marc Charette]] | [[National Heart, Lung, and Blood Institute]] | Program Director; Division of Cardiovascular Diseases | | | [[Marc Charette]] | [[National Heart, Lung, and Blood Institute]] | Program Director; Division of Cardiovascular Diseases | |
| | [[Tomas Cihlar]] | [[pharmaceutical_companies:Gilead Sciences]] | Vice President and Head of Virology | | | [[Tomas Cihlar]] | [[pharmaceutical_companies:Gilead Sciences]] | Vice President and Head of Virology | |
| | [[Christine Colvis]] | [[National Center for Advancing Translational Sciences]] | Director, Drug Development Partnership Programs]] | | | [[Christine Colvis]] | [[National Center for Advancing Translational Sciences]] | Director, Drug Development Partnership Programs | |
| | [[Michael Diamond]] | [[Washington University School of Medicine in St. Louis]] | The Herbert S. Gasser Professor, Departments of Medicine, Molecular Microbiology, Pathology & Immunology | | | [[Michael Diamond]] | [[Washington University School of Medicine in St. Louis]] | The Herbert S. Gasser Professor, Departments of Medicine, Molecular Microbiology, Pathology & Immunology | |
| | [[Ken Duncan]] | [[Bill & Melinda Gates Foundation]] | Deputy Director, Discovery – Therapeutics | | | [[Ken Duncan]] | [[Bill & Melinda Gates Foundation]] | Deputy Director, Discovery – Therapeutics | |
